Increasing Patient Inclusion in Cancer Clinical Trials
In the new ASCO in Action Podcast, Dr. Edward Kim and ASCO CEO Dr. Clifford A. Hudis examine issues and opportunities around eligibility criteria for cancer clinical trials. During the discussion, Dr. Kim noted that only three-to-five percent of U.S. cancer patients are eligible for clinical trials.
“It is really a travesty that the percentage is that low,” Dr. Kim said. “Out of every 100 patients we see with cancer… only three of them are eligible for clinical trials.”